Provision of Medications for Self-Managed Abortion Before and After the Dobbs v Jackson Women's Health Organization Decision

被引:12
|
作者
Aiken, Abigail R. A. [1 ]
Wells, Elisa S. [2 ]
Gomperts, Rebecca [3 ]
Scott, James G. [4 ]
机构
[1] Univ Texas Austin, LBJ Sch Publ Affairs, POB Y, Austin, TX 78712 USA
[2] Natl Womens Hlth Network, Plan C, Washington, DC USA
[3] Aid Access, Amsterdam, Netherlands
[4] Univ Texas Austin, McCombs Sch Business, Austin, TX 78712 USA
来源
基金
美国国家卫生研究院; 瑞典研究理事会;
关键词
TELEMEDICINE; MISOPROSTOL; MIFEPRISTONE; PREGNANCY; SAFE;
D O I
10.1001/jama.2024.4266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ImportanceThe Supreme Court decision in Dobbs v Jackson Women's Health Organization overturned the right to choose abortion in the US, with at least 16 states subsequently implementing abortion bans or 6-week gestational limits. Prior research indicates that in the 6 months following Dobbs, approximately 32 360 fewer abortions were provided within the US formal health care setting. However, trends in the provision of medications for self-managed abortion outside the formal health care setting have not been studied. ObjectiveTo determine whether the provision of medications for self-managed abortion outside the formal health care setting increased in the 6 months after Dobbs. Design, Setting, and ParticipantsCross-sectional study using data from sources that provided abortion medications outside the formal health care setting to people in the US between March 1 and December 31, 2022, including online telemedicine organizations, community networks, and online vendors. Using a hierarchical bayesian model, we imputed missing values from sources not providing data. We estimated the change in provision of medications for self-managed abortion after the Dobbs decision. We then estimated actual use of these medications by accounting for the possibility that not all provided medications are used by recipients. ExposureAbortion restrictions following the Dobbs decision. Main Outcomes and MeasuresProvision and use of medications for a self-managed abortion. ResultsIn the 6-month post-Dobbs period (July 1 to December 31, 2022), the total number of provisions of medications for self-managed abortion increased by 27 838 (95% credible interval [CrI], 26 374-29 175) vs what would have been expected based on pre-Dobbs levels. Excluding imputed data changes the results only slightly (27 145; 95% CrI, 25 747-28 246). Accounting for nonuse of medications, actual self-managed medication abortions increased by an estimated 26 055 (95% CrI, 24 739-27 245) vs what would have been expected had the Dobbs decision not occurred. Conclusions and RelevanceProvision of medications for self-managed abortions increased in the 6 months following the Dobbs decision. Results suggest that a substantial number of abortion seekers accessed services despite the implementation of state-level bans and restrictions.
引用
收藏
页码:1558 / 1564
页数:7
相关论文
共 50 条
  • [41] Impact of Dobbs v. Jackson Women's Health Organization on Professional Decision-Making Among Urology Applicants
    Peters, Chloe E.
    Seideman, Casey A.
    Kauderer, Sophie
    Gore, John L.
    Holt, Sarah K.
    Mehta, Akanksha
    Singer, Eric A.
    Tabakin, Alexandra L.
    Thavaseelan, Simone
    Vemulakonda, Vijaya
    Posid, Tasha
    Velez, Danielle
    UROLOGY, 2024, 187 : 49 - 54
  • [42] ONLINE TRENDS FOR VASECTOMY INQUIRIES FOLLOWING DOBBS V. JACKSON WOMEN'S HEALTH ORGANIZATION SUPREME COURT DECISION
    Dolendo, I
    Leach, M.
    Nguyen, V
    Uloko, M.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [43] Impact of Dobbs v. Jackson Women's Health Organization on Professional Decision-Making among Urology Applicants
    Griebling, Tomas L.
    UROLOGY, 2024, 187 : 55 - 55
  • [44] PERSPECTIVES OF SOCIETY OF WOMEN IN UROLOGY MEMBERS TOWARD DOBBS V. JACKSON WOMEN'S HEALTH ORGANIZATION
    Peters, Chloe E.
    Lee, Jenney
    Holt, Sarah K.
    Wolff, Erika M.
    Gore, John L.
    Seideman, Casey A.
    JOURNAL OF UROLOGY, 2023, 209 : E655 - E656
  • [45] A Critical Analysis of Dobbs v. Jackson Women's Health Organization and the Consequences of Fetal Personhood
    Manninen, Bertha Alvarez
    CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS, 2023, 32 (03) : 357 - 367
  • [46] Patients Before Policy: Caring for Pregnant Persons with Heart Failure in the Dobbs v. Jackson Women's Health Organization Era
    Reza, Nosheen
    Mentz, Robert J.
    Lala, Anuradha
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (06) : 861 - 862
  • [47] (Re)productive Dissent: Reproductive Justice in Dobbs v. Jackson Women's Health Organization
    Coker, Calvin R.
    Faulstick, Abigail
    WOMENS STUDIES IN COMMUNICATION, 2024, 47 (01) : 22 - 41
  • [48] VASECTOMY TRENDS IN WESTERN NY FOLLOWING DOBBS V. JACKSON WOMEN'S HEALTH ORGANIZATION
    Greenstein, A.
    Farah, G.
    Vecellio, P.
    Bradin, A.
    Chevli, K.
    Brennan, M.
    JOURNAL OF SEXUAL MEDICINE, 2024, 21
  • [49] Self-Managed Abortion Attempts Before vs After Changes in Federal Abortion Protections in the US
    Ralph, Lauren
    Schroeder, Rosalyn
    Kaller, Shelly
    Grossman, Daniel
    Biggs, M. Antonia
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [50] IMPACT OF DOBBS V. JACKSON WOMEN'S HEALTH ORGANIZATION ON INCIDENCE OF CHILDLESS AND PARTNERLESS VASECTOMY
    Vi Nguyen
    Li, Michelle K.
    Leach, Michelle C.
    Patel, Darshan P.
    Hsieh, Tung-Chin
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1244 - E1245